(Q35981425)

English

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee (English)

1 reference

Europe PubMed Central

11 August 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

object named as

Mannix KA

3

0 references

author name string

Carmichael J

1

1 reference

Europe PubMed Central

11 August 2017

Cantwell BM

2

1 reference

Europe PubMed Central

11 August 2017

Mannix KA

3

1 reference

Europe PubMed Central

11 August 2017

Veale D

4

1 reference

Europe PubMed Central

11 August 2017

Elford HL

5

1 reference

Europe PubMed Central

11 August 2017

Blackie R

6

1 reference

Europe PubMed Central

11 August 2017

Kerr DJ

7

1 reference

Europe PubMed Central

11 August 2017

Kaye SB

8

1 reference

Europe PubMed Central

11 August 2017

Harris AL

9

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 March 1990

1 reference

Europe PubMed Central

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

11 August 2017

61

1 reference

Europe PubMed Central

11 August 2017

3

1 reference

Europe PubMed Central

11 August 2017

447-450

1 reference

Europe PubMed Central

11 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1990.98

0 references

Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971305

2 October 2017

Levels of Ribonucleotide Reductase Activity during the Division Cycle of the L Cell

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971305

11 July 2018

Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971305

11 July 2018

Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971305

11 July 2018

Effect of hydroxyurea on ribonucleotide reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2183873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1 study of high-dose hydroxyurea in lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2183873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2183873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1990.98

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35981425&oldid=2143322914"